Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Neuroplastin (Nptn) is a cell adhesion molecule that is rich in synaptic membranes and belongs to the immunoglobulin superfamily. There are two isomers of np65 and np55. np65 is brain-specific and np55 is systemic. Neuroplastin can play a role in long-term enhancement, synaptic plasticity, and promotion of neurite outgrowth. It may be related to learning, memory, and emotion.
Figure 1. A strategy for preventing melanoma lung-tropic metastasis. (Tomonobu, N., et al. 2020)
Nptn and schizophrenia
Nptn belongs to the immunoglobulin superfamily of cell adhesion molecules and is mainly located on the synaptic membrane. Among them, np65 is a unique glycoprotein in the brain and is mainly present in neurons of the forebrain, while np55 exists in various regions and other tissues in the brain. In different organisms, np65 and np55 are highly glycosylated and present many different glycosylation forms. Part of the fucosylation of np65 is related to long-term memory formation and long term potentiation (LTP). The immunoreactivity of np65 in post-synaptic density area (PSD) is significantly increased, indicating that np65 can be transferred to PSD in order to maintain neuronal activity. And using np65 antibody or np65- Fc recombinant protein can inhibit LTP, which indicates that the maintenance of np65 and LTP is related to synaptic plasticity.
Gangliosides are present on the cell membrane and play an important role in the development and maintenance of central and peripheral nervous system functions. The expression of mRNA of Nptn in ganglioside-deficient mice was significantly increased, the expression of np55 protein was also significantly increased, and the np immune response in the CA1, CA3 region and the dentate gyrus molecular cell layer was significantly reduced. Because gangliosides and Nptn play important roles in synaptic transmission, synaptic plasticity, and neurite growth. Changes in the proportion of ganglioside composition types in the brain will affect the expression and distribution of Nptn. Therefore, Nptn and ganglioside interact.
The relationship between Nptn and emotional abnormalities
Schizophrenia is a common psychiatric disorder. It can be concluded that schizophrenia is genetically susceptible through the clustering of families and the incidence of twins. NPTN, located on chromosome 15q22, is a risk factor for schizophrenia and is thought to be related to visual attention in patients. A study of 200 schizophrenia patients in Japan showed that there is a single nucleotide polymorphism in the 5 'end promoter of NPTN, which exists in 4 forms. Among them, del-G-G is overexpressed in patients with schizophrenia, while TG-G appears more frequently in normal people than in patients. The presence of T-G-G in the promoter can reduce the transcription of NPTN, thereby interfering with the excessive affinity binding between np molecules, so T-G-T can be used as a protective factor for schizophrenia.
Nptn and breast cancer
Neuroplastin expression was found during screening of tumor cell antigens in the B-cell proliferative area of breast cancer patients' lymph nodes. In subsequent studies, it was found that the expression was mainly np55 with relative molecular masses of 45 000 and 55 000. Among patients with tumors with a positive neuroplastin expression, distant tumor metastasis was found in 50% of patients and lymph node metastasis was found in 20%, indicating that the expression of Neuroplastin increases the probability of tumor cell metastasis. Therefore, np55 may be used as a tumor marker for breast cancer, thus becoming an indicator of breast cancer screening and treatment effect detection. Studies have shown that the expression of Fibroblast Growth Factor Receptor-1 (FGFR1) is increased in 8% to 15% of breast cancer patients, which suggests that np55 activation of FGFR is an important pathophysiological process in some types of breast cancer patients.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.